FibroGen (NASDAQ:FGEN) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. FibroGen Stock Down 6.6 % FGEN opened at $0.34 on Friday. FibroGen has a twelve month low of $0.33 and a twelve month high of $2.93. The […]
More Stories
Easy Tips To Utilize For Enhancing Workplace Safety
Running a business involves more than finances and marketing. The safety of your workplace is one of the most important...
Brown & Brown, Inc. (NYSE:BRO) Receives Consensus Rating of “Moderate Buy” from Brokerages
Shares of Brown & Brown, Inc. (NYSE:BRO – Get Free Report) have been assigned an average rating of “Moderate Buy”...
Generac Holdings Inc. (NYSE:GNRC) Receives Average Recommendation of “Hold” from Analysts
Shares of Generac Holdings Inc. (NYSE:GNRC – Get Free Report) have been assigned a consensus rating of “Hold” from the...
Brokerages Set UiPath Inc. (NYSE:PATH) Target Price at $17.71
UiPath Inc. (NYSE:PATH – Get Free Report) has been assigned a consensus rating of “Hold” from the eighteen ratings firms...
Concentrix Co. (NASDAQ:CNXC) Given Consensus Recommendation of “Buy” by Brokerages
Concentrix Co. (NASDAQ:CNXC – Get Free Report) has been given a consensus recommendation of “Buy” by the six research firms...
Contrasting BioLargo (BLGO) and Its Competitors
BioLargo (NASDAQ:BLGO – Get Free Report) is one of 34 publicly-traded companies in the “Chemicals & allied products” industry, but...